Expert Review of Precision Medicine and Drug Development, Volume 7, Issue 1 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Precision Medicine and Drug Development, Volume 7, Issue 1 (2022)

See all volumes and issues
Vol 9, 2024 Vol 8, 2023 Volume 7, 2022 Vol 6, 2021 Vol 5, 2020 Vol 4, 2019 Vol 3, 2018 Vol 2, 2017 Vol 1, 2016
Download citations Download PDFs Download issue

Editorial

Editorial
Combining immune checkpoint inhibitors with locoregional therapies in hepatocellular carcinoma
Alessandro Rizzo, Angela Dalia Ricci & Giovanni Brandi
Pages: 1-3
Published online: 27 Dec 2021
First Page PreviewforCombining immune checkpoint inhibitors with locoregional therapies in hepatocellular carcinoma | Full Text | References | PDF (143.4 KB) | EPUB
  • 1072 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Review

Review
Personalizing treatments for patients based on cardiovascular phenotyping
Jane A. Leopold
Pages: 4-16
Published online: 24 Jan 2022
AbstractforPersonalizing treatments for patients based on cardiovascular phenotyping | Full Text | References | PDF (2.9 MB) | EPUB
  • 264 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Personalised pharmacotherapy options for soft tissue sarcomas
Samia Arifi
Pages: 17-28
Published online: 10 Mar 2022
AbstractforPersonalised pharmacotherapy options for soft tissue sarcomas | Full Text | References | PDF (325.2 KB) | EPUB
  • 124 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Identification of drug combinations for lung cancer patients whose tumors are unresponsive to targeted therapy: clinical bases and future directions
Danilo Rocco, Luigi Della Gravara, Paolo Maione, Giovanni Palazzolo & Cesare Gridelli
Pages: 29-38
Published online: 11 Mar 2022
AbstractforIdentification of drug combinations for lung cancer patients whose tumors are unresponsive to targeted therapy: clinical bases and future directions | Full Text | References | PDF (1.5 MB) | EPUB
  • 61 Views
  • 0 CrossRef citations
  • 0Altmetric

Special Report

Article
Non-alcoholic fatty liver disease - opportunities for personalized treatment and drug development
Aurino M. Kemas, Sonia Youhanna & Volker M. Lauschke
Pages: 39-49
Published online: 24 Mar 2022
AbstractforNon-alcoholic fatty liver disease - opportunities for personalized treatment and drug development | Full Text | References | PDF (802.7 KB) | EPUB
  • 2229 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Perspective

Article
Predictors of response for hepatocellular carcinoma immunotherapy: is there anything on the horizon?
Alessandro Rizzo & Angela Dalia Ricci
Pages: 50-57
Published online: 15 May 2022
AbstractforPredictors of response for hepatocellular carcinoma immunotherapy: is there anything on the horizon? | Full Text | References | PDF (1.3 MB) | EPUB
  • 45 Views
  • 1 CrossRef citations
  • 0Altmetric

Editorial

Editorial
PD-L1 assessment in breast cancer immunotherapy: a critical overview
Angela Dalia Ricci, Alessandro Rizzo, Gennaro Palmiotti & Giovanni Brandi
Pages: 58-59
Published online: 30 Jun 2022
CitationforPD-L1 assessment in breast cancer immunotherapy: a critical overview | Full Text | References | PDF (140 KB) | EPUB
  • 673 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Ramucirumab or merestinib in biliary tract cancer: new combinations, old mistakes?
Alessandro Rizzo, Alessandro Di Federico, Gennaro Palmiotti & Giovanni Brandi
Pages: 60-61
Published online: 30 Jun 2022
CitationforRamucirumab or merestinib in biliary tract cancer: new combinations, old mistakes? | Full Text | References | PDF (118.2 KB) | EPUB
  • 433 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Perspective

Article
Development pathways for subcutaneous formulations of biologics versus biosimilar development
Artem Zharkov, Bettina Barton, Dominik Heinzmann, Georgios Bakalos & Thomas Schreitmüller
Pages: 62-69
Published online: 01 Mar 2019
AbstractforDevelopment pathways for subcutaneous formulations of biologics versus biosimilar development | Full Text | References | PDF (837.2 KB) | EPUB
  • 11980 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Capabilities of neural network technologies for extracting new medical knowledge and enhancing precise decision making for patients
Leonid N. Yasnitsky, Andrey A. Dumler, Fedor M. Cherepanov, Vitaly L. Yasnitsky & Natalia A. Uteva
Pages: 70-78
Published online: 01 Nov 2021
AbstractforCapabilities of neural network technologies for extracting new medical knowledge and enhancing precise decision making for patients | Full Text | References | PDF (1.8 MB) | EPUB
  • 45 Views
  • 1 CrossRef citations
  • 0Altmetric

Review

Review
Dopaminergic and other genes related to reward induced overeating, Bulimia, Anorexia Nervosa, and Binge eating
Kenneth Blum, Panayotis K. Thanos, Gene -Jack Wang, Abdalla Bowirrat, Luis Llanos Gomez, David Baron, Rehan Jalali, Marjorie C Gondré-Lewis & Mark S Gold
Pages: 79-95
Published online: 15 Nov 2021
AbstractforDopaminergic and other genes related to reward induced overeating, Bulimia, Anorexia Nervosa, and Binge eating | Full Text | References | PDF (4.9 MB) | EPUB
  • 173 Views
  • 0 CrossRef citations
  • 0Altmetric

Drug Profile

Article
A profile on capmatinib in treating adult patients with metastatic NSCLC tumors with MET exon 14 skipping mutations
Toyoaki Hida
Pages: 96-101
Published online: 10 Nov 2021
AbstractforA profile on capmatinib in treating adult patients with metastatic NSCLC tumors with MET exon 14 skipping mutations | Full Text | References | PDF (1.4 MB) | EPUB
  • 45 Views
  • 0 CrossRef citations
  • 0Altmetric

Editorial

Editorial
Precision oncology in cholangiocarcinoma: current issues in clinical trial design and access to targeted therapies
Alessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola & Giovanni Brandi
Pages: 102-104
Published online: 29 Nov 2021
First Page PreviewforPrecision oncology in cholangiocarcinoma: current issues in clinical trial design and access to targeted therapies | Full Text | References | PDF (1,011.6 KB) | EPUB
  • 657 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Review

Review
Therapeutic potential of GABAA receptor subunit expression abnormalities in fragile X syndrome
Mathijs B. van der Lei & R. Frank Kooy
Pages: 105-120
Published online: 04 Jan 2022
AbstractforTherapeutic potential of GABAA receptor subunit expression abnormalities in fragile X syndrome | Full Text | References | PDF (710.8 KB) | EPUB
  • 193 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Challenges in biomarker-based clinical trials for patients with gastrointestinal malignancies
Jeremy D. Kratz, Wei Zhang, Monica Patel & Nataliya V. Uboha
Pages: 121-130
Published online: 15 Aug 2022
AbstractforChallenges in biomarker-based clinical trials for patients with gastrointestinal malignancies | Full Text | References | PDF (253.9 KB) | EPUB
  • 35 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Guiding treatment selection with immunotherapy compared to targeted therapy agents in patients with metastatic kidney cancer
Matteo Rosellini, Andrea Marchetti, Elisa Tassinari, Giacomo Nuvola, Alessandro Rizzo, Matteo Santoni, Veronica Mollica & Francesco Massari
Pages: 131-149
Published online: 18 Dec 2022
AbstractforGuiding treatment selection with immunotherapy compared to targeted therapy agents in patients with metastatic kidney cancer | Full Text | References | PDF (1.5 MB) | EPUB
  • 55 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Accelerating precision ophthalmology: recent advances
Loay Rahman, Ammaarah Hafejee, Rajeevan Anantharanjit, Wei Wei & Maria Francesca Cordeiro
Pages: 150-161
Published online: 22 Dec 2022
AbstractforAccelerating precision ophthalmology: recent advances | Full Text | References | PDF (385 KB) | EPUB
  • 666 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Special Report

Article
Prediction and early diagnosis of immune-checkpoint inhibitor-induced inflammatory arthritis from molecular biomarkers – Where are we now?
Christopher Aboo, Tue Wenzel Krastrup, Helene Broch Tenstad, Jie Ren, Søren Andreas Just, Morten Ladekarl & Allan Stensballe
Pages: 162-168
Published online: 22 Dec 2022
AbstractforPrediction and early diagnosis of immune-checkpoint inhibitor-induced inflammatory arthritis from molecular biomarkers – Where are we now? | Full Text | References | PDF (1.4 MB) | EPUB
  • 70 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Precision Medicine Paradigms in Allergic Rhinitis: Navigating Immunotherapy and Digital Healthcare
Rutuja Vinchurkar et al.
Review Article | Published online: 8 Jul 2024
Open Access
Advanced laboratory techniques in diffuse large B-cell lymphoma treated with CAR-T: the role for pathologists
Phillip D. Michaels
Editorial | Published online: 15 Apr 2024
Open Access
Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma
Veronica Mollica et al.
Article | Published online: 18 Mar 2024
Open Access
Advances in the field of developing biomarkers for re-irradiation: a how-to guide to small, powerful data sets and artificial intelligence
Chaudhry Huma et al.
Review Article | Published online: 11 Mar 2024
Open Access
View all latest articles